参考文献/References:
[1] Clifton P,Carter S,Headland M,et al.Low carbohydrate and ketogenic diets in type 2 diabetes[J].Curr Opin Lipidol,2015,26(6):594-595. DOI:10.1097/MOL.0000000000000241.
[2] Gupta L,Khandelwal D,Kalra S, et al.Ketogenic diet in endocrine disorders: current perspectives[J]. J Postgrad Med,2017,63(4):242-251. DOI: 10.4103/jpgm.JPGM_16_17.
[3] Kanikarla-Marie P,Jain SK.Hyperketonemia and ketosis increase the risk of complications in type 1 diabetes[J].Free Radic Biol Med,2016,95:268-277. DOI:10.1016/j.freeradbiomed.2016.03.020.
[4] Abbasi J.Interest in the ketogenic diet grows for weight loss and type 2 diabetes[J].JAMA 2018,319(3):215-217.DOI:10.1001/jama.2017.20639.
[5] Zhang X,Qin J,Zhao Y,et al.Long-term ketogenic diet contributes to glycemic control but promotes lipid accumulation and hepatic steatosis in type 2 diabetic mice[J].Nutr Res,2016,36(4):349-358. DOI:10.1016/j.nutres.2015.
[6] Gibas MK,Gibas KJ. Induced and controlled dietary ketosis as a regulator of obesity and metabolic syndrome pathologies[J].Diabetes Metab Syndr,2017,(Suppl 1):S385-S390. DOI: 10.1016/j.dsx.2017.03.022.
[7] Fred B.Overweight and diabetes prevention: is a low-carbohydrate-high-fat diet recommendable?[J]. Eur J Nutr,2018,57(4):1301-1312. DOI: 10.1007/s00394-018-1636-y.
[8] Muscogiuri G,Palomba S,Laganà AS,et al.Current insights into inositol isoforms, mediterranean and ketogenic diets for polycystic ovary syndrome: from bench to bedside[J].Curr Pharm Des,2016,22(36):5554-5557.DOI:10.2174/1381612822666160720160634.
[9] Kosinski C, Jornayvaz FR. Effects of ketogenic kiets on cardiovascular risk factors:evidence from animal and human studies[J]. Nutrients,2017,9(5):pii:E517. DOI: 10.3390/nu9050517.
[10] Magnusdottir OK, Gunnarsdottir I, Birgisdóttir BE.Dietary guidelines in type 2 diabetes: the Nordic diet or the ketogenic diet [J]. Curr Opin Endocrinol Diabetes Obes, 2017,24(5):315-319. DOI: 10.1097/MED.0000000000000361.
[11] Leow ZZX,Guelfi KJ,Davis EA,et al.The glycaemic benefits of a very-low-carbohydrate ketogenic diet in adults with type 1 diabetes mellitus may be opposed by increased hypoglycaemia risk and dyslipidaemia[J]. Diabet Med, 2018, [Epub ahead of print]. DOI: 10.1111/dme.13663.
[12] Saslow LR,Mason AE,Kim S,et al.An online intervention comparing a very low-carbohydrate ketogenic diet and lifestyle recommendations versus a plate method diet in overweight individuals with type 2 diabetes: a randomized controlled trial[J]. J Med Internet Res,2017,19(2):e36. DOI:10.2196/jmir.5806.
[13] Goday A,Bellido D,Sajoux I,et al.Short-term safety, tolerability and efficacy of a very low-calorie-ketogenic diet interventional weight loss program versus hypocaloric diet in patients with type 2 diabetes mellitus[J]. Nutr Diabetes,2016,6(9):e230. DOI:10.1038/nutd.2016.36.
[14] Zhang Q,Xu L,Xia J,et al.Treatment of diabetic mice with a combination of ketogenic diet and aerobic exercise via modulations of PPARs gene programs[J].PPAR Res,2018,2018:4827643.DOI:10.1155/2018/4827643.
[15] Gomez-Arbelaez D,Crujeiras AB,Castro AI,et al.Acid-base safety during the course of a very low-calorie-ketogenic diet[J]. Endocrine, 2017,58(1):81-90. DOI: 10.1007/s12020-017-1405-3.
[16] Lodi A,Karsten B,Bosco G,et al.The Effects of different high-protein low-carbohydrates proprietary foods on blood sugar in healthy subjects[J].J Med Food, 2016,19(11):1085-1095. DOI:10.1089/jmf.2016.0072.
[17] Giugliano D,Maiorino MI,Bellastella G,et al.More sugar? No, thank you! The elusive nature of low carbohydrate diets[J]. Endocrine, 2018,61(3):383-387.DOI:10.1007/s12020-018-1580-x.
相似文献/References:
[1]李春睿,王静,陈峰,等.GLP-1受体激动剂对糖尿病患者肾功能的影响[J].国际内分泌代谢杂志,2014,(06):401.[doi:10.3760/cma.j.issn.1673-4157.2014.06.011]
Li Chunrui*,Wang Jing,Chen Feng,et al.Effects of GLP-1 receptor agonists on renal function of diabetics[J].International Journal of Endocrinology and Metabolism,2014,(06):401.[doi:10.3760/cma.j.issn.1673-4157.2014.06.011]
[2]黄珊珊,鲁一兵.长链非编码RNA与糖尿病[J].国际内分泌代谢杂志,2015,(04):271.[doi:10.3760/cma.j.issn.1673-4157.2015.04.016]
Huang Shanshan*,Lu Yibing..Long non-coding RNA and diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2015,(06):271.[doi:10.3760/cma.j.issn.1673-4157.2015.04.016]
[3]高瑞霄,姚朱华,冯凭,等.尿8-羟基脱氧鸟苷在2型糖尿病及糖尿病合并冠心病患者中的临床意义[J].国际内分泌代谢杂志,2014,(05):295.[doi:10.3760/cma.j.issn.1673-4157.2014.05.002]
Gao Ruixiao*,Yao Zhuhua,Feng Ping,et al.The clinical significance of urinary 8-hydroxy deoxyguanosine in patients with type 2 diabetes mellitus and diabetic patients with coronary heart disease[J].International Journal of Endocrinology and Metabolism,2014,(06):295.[doi:10.3760/cma.j.issn.1673-4157.2014.05.002]
[4]郑佳,肖新华.葡萄糖稳态的中枢调控作用机制
——2014年美国糖尿病协会“杰出科学成就奖”
演讲报告解读[J].国际内分泌代谢杂志,2014,(05):305.[doi:10.3760/cma.j.issn.1673-4157.2014.05.004]
Zheng Jia,Xiao Xinhua.The mechanisms of central nervous system in the control of glucose homeostasis--A summary of 2014 ADA "Outstanding Scientific Achievement Award" Lecture[J].International Journal of Endocrinology and Metabolism,2014,(06):305.[doi:10.3760/cma.j.issn.1673-4157.2014.05.004]
[5]唐勤,邵莉.蛋白乙酰化与胰岛素分泌[J].国际内分泌代谢杂志,2014,(05):313.[doi:10.3760/cma.j.issn.1673-4157.2014.05.007]
Tang Qin,Shao Li..Protein acetylation and insulin secretion[J].International Journal of Endocrinology and Metabolism,2014,(06):313.[doi:10.3760/cma.j.issn.1673-4157.2014.05.007]
[6]卢婷婷,任思佳,沈捷.人群迁徙对糖尿病患病率的影响及其相关因素[J].国际内分泌代谢杂志,2014,(05):327.[doi:10.3760/cma.j.issn.1673-4157.2014.05.011]
Lu Tingting,Ren Sijia,Shen Jie..Impact of migration on prevalence of diabetes and risk factors[J].International Journal of Endocrinology and Metabolism,2014,(06):327.[doi:10.3760/cma.j.issn.1673-4157.2014.05.011]
[7]包薇萍,陈国芳,刘超.DPP-4抑制剂的肾保护作用[J].国际内分泌代谢杂志,2014,(05):337.[doi:10.3760/cma.j.issn.1673-4157.2014.05.014]
Bao Weiping,Chen Guofang,Liu Chao..Renal protective effects of dipeptidyl peptidase-4 inhibitors[J].International Journal of Endocrinology and Metabolism,2014,(06):337.[doi:10.3760/cma.j.issn.1673-4157.2014.05.014]
[8]孟庆冬,陶红.巨噬细胞凋亡与糖尿病动脉粥样硬化[J].国际内分泌代谢杂志,2014,(05):340.[doi:10.3760/cma.j.issn.1673-4157.2014.05.015]
Meng Qingdong,Tao Hong..Macrophage apoptosis and diabetic atherosclerosis[J].International Journal of Endocrinology and Metabolism,2014,(06):340.[doi:10.3760/cma.j.issn.1673-4157.2014.05.015]
[9]赵荷珺 洪天配.胰高血糖素样肽-1类药物与胰腺安全性[J].国际内分泌代谢杂志,2015,(05):319.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.008]
Zhao Hejun*,Hong Tianpei..Glucagon-like peptide-1-based therapies and pancreatic safety[J].International Journal of Endocrinology and Metabolism,2015,(06):319.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.008]
[10]吕丹 李晓思 陈树春 王泽普.Betatrophin:糖尿病再生治疗的新希望[J].国际内分泌代谢杂志,2015,(05):351.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.016]
Lyu Dan*,Li Xiaosi,Chen Shuchun,et al.Betatrophin:new hope for regeneration therapy of diabetes[J].International Journal of Endocrinology and Metabolism,2015,(06):351.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.016]